Application 075091
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET, EXTENDED RELEASE;ORAL | 50MG;200MG | No | No |
| 002 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET, EXTENDED RELEASE;ORAL | 25MG;100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075091-001 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | |
| A075091-002 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075091-001 | AB |
| A075091-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A075091-001 | CARBIDOPA AND LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 1999-09-30 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A075091-002 | CARBIDOPA AND LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2000-04-21 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075091-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075091-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075091-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075091-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075091-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075091-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075091-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075091-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075091-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075091-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075091-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075091-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075091-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075091-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075091-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075091-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075091-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075091-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A075091-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075091-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075091-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075091-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075091-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075091-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075091-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075091-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A075091-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A075091-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075091-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075091-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A075091-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A075091-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A075091-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A075091-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A075091-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A075091-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A075091-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A075091-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A075091-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A075091-002 | AB | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Pharmaceuticals Inc. | aa5028d6-fd0a-4cf1-b708-c93bb2a7c76a | 2026-04-24 | Warnings, Adverse reactions | 075091 ANDA075091 0378-0094 0378-0088 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Safecor Health, LLC | 015bc056-ee86-4006-ae7c-689b95e566f4 | 2026-03-19 | Warnings, Adverse reactions | 075091 ANDA075091 |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Institutional Inc. | 16f9e4d1-6953-4d4f-b4cf-ad95a856ac25 | 2025-07-18 | Warnings, Adverse reactions | 075091 ANDA075091 51079-978 51079-923 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-0088 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0088 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0088 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0088 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0088 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0094 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0094 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0094 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0094 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0094 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0615-4568 | Carbidopa and Levodopa | Carbidopa and Levodopa | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 0615-4569 | Carbidopa and Levodopa | Carbidopa and Levodopa | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 43353-327 | Carbidopa and Levodopa | carbidopa and levodopa | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-327 | Carbidopa and Levodopa | carbidopa and levodopa | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 51079-923 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 51079-923 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 51079-923 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 51079-978 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 51079-978 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 51079-978 | Carbidopa and Levodopa | carbidopa and levodopa | Mylan Institutional Inc. | ANDA | Current |
| 67544-672 | Carbidopa and Levodopa | carbidopa and levodopa | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-672 | Carbidopa and Levodopa | carbidopa and levodopa | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |